Asset Details
Do you wish to reserve the book?
Prevalence of asthma in preterm and associated risk factors based on prescription data from the Korean National Health Insurance database
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Prevalence of asthma in preterm and associated risk factors based on prescription data from the Korean National Health Insurance database
Do you wish to request the book?
Prevalence of asthma in preterm and associated risk factors based on prescription data from the Korean National Health Insurance database
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Prevalence of asthma in preterm and associated risk factors based on prescription data from the Korean National Health Insurance database
2023
Overview
We retrospectively analyzed National Health Insurance claims data (January 2002–December 2018) to determine the asthma prevalence and risk factors among preterm infants born in Korea. Patients with asthma were defined as those with a history of asthma medication prescriptions at least twice per year with International Classification of Diseases, Tenth Edition codes J45 and J46. We enrolled 99,139 preterm infants. The prevalence of asthma among preterm and term infants was 32.7% and 26.9%, 21.2% and 19.1%, 6.7% and 5.9%, 2.0%, and 1.6%, and 2.4% and 1.6% at 2, 5, 10, 15, and 16 years of age, respectively. The relative risk (RR) of asthma in preterm infants was 1.1-fold that in female preterm infants. The RR of asthma medication prescriptions for infants with extreme prematurity was 1.92-fold that of infants with moderate/late pre-term status. Among preterm with bronchopulmonary dysplasia (BPD) and respiratory distress syndrome (RDS) without comorbidities, the RRs for the number of asthma medication prescriptions were 1.34 and 1.06, respectively. This study revealed a higher prevalence of asthma among preterm infants than that in term infants. Male sex, extreme prematurity, BPD, and RDS were identified as risk factors for asthma medication prescriptions in preterm infants.
Publisher
Springer Science and Business Media LLC,Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
Subject
/ Asthma
/ Bronchopulmonary Dysplasia - epidemiology
/ Drugs
/ Female
/ Humanities and Social Sciences
/ Humans
/ Infant
/ Infants
/ Male
/ Medicine
/ Neonates
/ Q
/ R
/ Republic of Korea - epidemiology
/ Respiratory distress syndrome
/ Respiratory Distress Syndrome, Newborn
/ Respiratory Distress Syndrome, Newborn - drug therapy
/ Science
